The Current Ratio as of December 2025 (TTM) for Bioptik Technology Incorporation (4161.TWO) is 2.07

According to Bioptik Technology Incorporation’s latest financial reports and current stock price. The company's current Current Ratio is 2.07. This represents a change of 6.60% compared to the average of 1.94 of the last 4 quarters.

Bioptik Technology Incorporation (4161.TWO) Historical Current Ratio (quarterly & annually)

How has 4161.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Bioptik Technology Incorporation over the last ten years is 1.64. The current 2.07 Current Ratio has changed 12.53% with respect to the historical average. Over the past ten years (40 quarters), 4161.TWO's Current Ratio was at its highest in in the June 2025 quarter at 2.07. The Current Ratio was at its lowest in in the December 2022 quarter at 1.41.

Bioptik Technology Incorporation (4161.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bioptik Technology Incorporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bioptik Technology Incorporation (4161.TWO) Average Current Ratio

How has 4161.TWO Current Ratio performed in the past?

The current Current Ratio of Bioptik Technology Incorporation (4161.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bioptik Technology Incorporation (4161.TWO) Current Ratio vs. Peers

How is 4161.TWO’s Current Ratio compared to its peers?

Bioptik Technology Incorporation’s Current Ratio is greater than Lagis Enterprise Co., Ltd. (1.79), less than AViTA Corporation (2.15), less than Perfect Medical Industry Co., Ltd. (2.12), less than Genetics Generation Advancement Corp. (2.68), less than NaviFUS Corp. (15.39), greater than Enimmune corporation (1.41), less than Holy Stone Healthcare Co., Ltd. (7.56), less than GenMont Biotech Incorporation (4.38), greater than Arich Enterprise Co., Ltd. (1.38), less than GeneReach Biotechnology Corp. (2.23),

Build a custom stock screener for Bioptik Technology Incorporation (4161.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioptik Technology Incorporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bioptik Technology Incorporation (4161.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bioptik Technology Incorporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.